BIOL - BIOLASE, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
1.2868
+0.0568 (+4.62%)
As of 2:14PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.2300
Open1.2400
Bid1.2500 x 1200
Ask1.2800 x 800
Day's Range1.2200 - 1.3300
52 Week Range1.1400 - 5.3500
Volume108,239
Avg. Volume123,917
Market Cap26.349M
Beta1.00
PE Ratio (TTM)N/A
EPS (TTM)-1.3180
Earnings DateAug 6, 2018 - Aug 10, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2005-06-24
1y Target Est4.50
Trade prices are not sourced from all markets
  • PR Newswire7 hours ago

    BIOLASE Appoints Todd A. Norbe and Jess Roper to Board of Directors

    IRVINE, Calif., June 19, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, announced today that it has appointed veteran senior dental industry executive, Todd A. Norbe and veteran senior finance executive Jess Roper to its Board of Directors, effective immediately.  Mr. Roper will become chairman of the audit committee and replace James R. Talevich, who resigned from the Board due to other commitments.  The addition of Mr. Norbe increases the size of the Board to five directors. "The addition of Todd and Jess creates a reinvigorated Board of Directors with direct expertise in new technology adoption, disruptive innovation, and growth," said BIOLASE Chairman Jonathan T. Lord, M.D. "We have also increased the 'dental IQ' of the Company by adding a director with deep experience in the dental industry.

  • PR Newswire14 days ago

    BIOLASE Teams Up with Healthy Smiles For Kids of Orange County

    Initiative will deliver dental care to underserved communities using the latest dental laser technologies IRVINE, Calif. , June 5, 2018 /PRNewswire/ --  BIOLASE, Inc. (NASDAQ: BIOL), the global leader ...

  • ACCESSWIRE19 days ago

    Free Research Report as Hologic’s Revenues Jumped 10.3% and Adjusted EPS Climbed 6%

    LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free earnings report on Hologic, Inc. (NASDAQ: HOLX), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=HOLX. The Company reported its second quarter fiscal 2018 operating and financial results on May 02, 2018. Active-Investors.com is currently working on the research report for BIOLASE, Inc. (NASDAQ: BIOL), which also belongs to the Healthcare sector as the Company Hologic.

  • PR Newswire20 days ago

    BIOLASE Regains Compliance With Nasdaq Minimum Bid Price Requirement

    IRVINE, Calif. , May 30, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL) ("BIOLASE" or the "Company"), the global leader in dental lasers, today announced that it has received a letter ...

  • PR Newswirelast month

    Biolase Announces 1-for-5 Reverse Stock Split Common Stock Will Begin Trading On Split-Adjusted Basis On May 11

    IRVINE, Calif. , May 10, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL) ("BIOLASE" or the "Company"), today announced that at its annual meeting of stockholders held on May 9, 2018 ...

  • PR Newswirelast month

    BIOLASE and Los Angeles Chargers Partner to Bring Advanced Dental Care to Children in Underserved Communities in Southern California

    LOS ANGELES and IRVINE, Calif., May 9, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, and the Los Angeles Chargers today announced a partnership to bring advanced dental care to children in underserved communities in Southern California. The partnership aims to fill the gap of untreated dental conditions by raising awareness of and increasing access to dentistry's most advanced technologies for those communities in need.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of BIOL earnings conference call or presentation 2-May-18 8:30pm GMT

    Q1 2018 BIOLASE Inc Earnings Call

  • Associated Press2 months ago

    Biolase: 1Q Earnings Snapshot

    The Irvine, California-based company said it had a loss of 5 cents per share. Losses, adjusted for stock option expense and non-recurring costs, came to 4 cents per share. The maker of dental laser systems ...

  • PR Newswire2 months ago

    BIOLASE Reports 2018 First Quarter Results

    IRVINE, Calif. , May 2, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for its first quarter ended March 31, 2018 . Net revenue ...

  • PR Newswire2 months ago

    BIOLASE® To Host 2018 First Quarter Financial Results Conference Call On May 2, 2018

    IRVINE, Calif. , April 25, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Wednesday, May 2, 2018 ...

  • PR Newswire2 months ago

    BIOLASE Establishes Southern California Dental Advisory Board

    Industry leaders join forces to deliver thought leadership on laser dentistry and improve patient outcomes IRVINE, Calif. , April 17, 2018 /PRNewswire/ --  BIOLASE, Inc.  (NASDAQ: BIOL), the global leader ...

  • PR Newswire2 months ago

    BIOLASE Board Of Directors Asks Chairman Jonathan T. Lord, M.D. To Take On Expanded Leadership Role And Explore Strategic Options

    IRVINE, Calif., April 11, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the world's leading manufacturer and distributor of dental lasers and a pioneer in laser surgery in other medical specialties, today announced that its Board of Directors ("Board") has asked Jonathan T. Lord, M.D., Chairman of the Board of BIOLASE, to lead the Company's exploration of a wide range of strategic alternatives, as well as the implementation of the recent Southern California initiatives to significantly enhance the region's oral health and dental care by increasing awareness and education in laser dentistry. The Board has also appointed Chief Financial Officer John R. Beaver as Interim Chief Executive Officer to focus on business performance improvement and continuing operational efficiencies.  Mr. Beaver replaces Harold C. Flynn, Jr., who has resigned from his positions as President, Chief Executive Officer and Director of the Company to pursue other interests.

  • PR Newswire2 months ago

    BIOLASE Names Garrett Sato To Board Of Directors

    IRVINE, Calif. , April 4, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has named veteran dental industry and financial services executive ...

  • PR Newswire3 months ago

    BIOLASE Announces Growing Awareness of Dental Lasers Among Pediatric Dentists, Demonstrating Shift Toward Pain-Free Dentistry

    IRVINE, Calif., March 28, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, announced today that the demand for pain-free care increases as awareness of the  more patient-friendly benefits of using dental lasers is growing in pediatric dentistry. With BIOLASE all-tissue dental lasers, pediatric dentists can treat even their youngest patients with little to no anesthesia, allowing dentists to intervene earlier in the management of children's dental conditions, such as tooth decay. Minimally invasive treatment with a dental laser allows for increased patient acceptance of treatment and practice growth.

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of BIOL earnings conference call or presentation 14-Mar-18 8:30pm GMT

    Q4 2017 BIOLASE Inc Earnings Call

  • Associated Press3 months ago

    Biolase reports 4Q loss

    On a per-share basis, the Irvine, California-based company said it had a loss of 5 cents. Losses, adjusted for stock option expense and non-recurring costs, came to 4 cents per share. The maker of dental ...

  • PR Newswire3 months ago

    BIOLASE Reports 2017 Fourth Quarter And Full-Year Results

    IRVINE, Calif. , March 14, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for its fourth quarter and year ended December 31, ...

  • ACCESSWIRE3 months ago

    BIOLASE, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 14, 2018 / BIOLASE, Inc. (NASDAQ: BIOL ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 14, 2018, at 4:30 PM Eastern Time. To ...

  • Is It Too Late To Buy BIOLASE Inc (NASDAQ:BIOL)?
    Simply Wall St.3 months ago

    Is It Too Late To Buy BIOLASE Inc (NASDAQ:BIOL)?

    BIOLASE Inc (NASDAQ:BIOL), a medical equipment company based in United States, led the NasdaqCM gainers with a relatively large price hike in the past couple of weeks. Less-covered, small capsRead More...

  • PR Newswire3 months ago

    BIOLASE Secures $6 Million Revolving Line Of Credit

    IRVINE, Calif., March 7, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, today announced that it has secured a $6 million revolving line of credit from Bridge Bank, a division of Western Alliance Bank. Funds from the two-year accounts receivable line of credit will be used for working capital purposes.

  • PR Newswire3 months ago

    BIOLASE® To Host 2017 Fourth Quarter Financial Results Conference Call On March 14, 2018

    IRVINE, Calif. , March 6, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Wednesday, March 14, 2018 ...

  • PR Newswire4 months ago

    BIOLASE Announces Memorandum Of Understanding With S-Ray To Market, Sell Disruptive Radiation-Free Dental Imaging Device

    IRVINE, Calif., Feb. 27, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, today announced that it has executed a non-binding Memorandum of Understanding ("MOU") with Redmond, WA-based S-Ray Incorporated ("S-Ray") to exclusively market and sell S-Ray's patented ClearView SCAN™ system, a disruptive and innovative ultrasound-based intraoral imaging system in the North American dental markets. ClearView SCAN is designed to be adjunct radiation-free imaging for soft-tissue anatomy that radiographs fail to detect, delivering a new category of imaging capability to clinicians for diagnosis and treatment planning. The MOU, which is subject to the negotiation and execution of a definitive agreement between BIOLASE and S-Ray, covers the multi-year terms of the exclusive distribution and service arrangement for the ClearView SCAN system.

  • PR Newswire4 months ago

    BIOLASE Announces Initiatives to Increase Dental Laser Awareness and Education in Southern California

    IRVINE, Calif., Feb. 15, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, announced today that it is bolstering its efforts in Southern California to significantly enhance the region's oral health and dental care by increasing awareness and education in laser dentistry. BIOLASE is adding local specialists to its staff to offer dentists more support in maximizing the use of their lasers.

  • PR Newswire4 months ago

    Nasdaq Grants BIOLASE 180-Day Extension To Meet Minimum Bid Price Requirement

    IRVINE, Calif. , Feb. 7, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the world's leading dental laser company, today announced that the Listing Qualifications Department of the Nasdaq Stock Market ...

  • PR Newswire5 months ago

    BIOLASE Rejects Frivolous, Abusive Patent Litigation

    IRVINE, Calif., Jan. 25, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the world's leading dental laser company, today released the following statement in response to the latest attempt by CAO Group, Inc. to use patent litigation to try to improve its competitive position in the marketplace. BIOLASE is well-known for its own innovations, and for respecting the valid intellectual property rights of others. It is not surprising that CAO has failed for years in its attempts to intimidate BIOLASE through abusive patent litigation.